secwatch.observer — SEC 8-K summary
======================================

Issuer:     PUMA BIOTECHNOLOGY, INC. (PBYI)
CIK:        0001401667
Form:       8-K
Filed at:   2022-06-17T23:59:59+00:00
Accession:  0001437749-22-015291
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Puma Biotechnology shareholders elect directors, ratify KPMG, approve say-on-pay at 2022 annual meeting
--------------------------------------------------------------------------------

- All seven director nominees elected: Auerbach (29.9M for, 0.9M withheld), Wilson (20.4M for, 10.4M withheld).
- KPMG ratified as independent auditor for FY2022 with 37.1M votes for, 0.5M against, 0.1M abstain.
- Advisory vote on executive compensation approved: 27.1M for, 3.6M against, 0.1M abstain, with 6.95M broker non-votes.
- Meeting held June 14, 2022; all proposals passed with broker non-votes on director and say-on-pay proposals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1401667/000143774922015291/0001437749-22-015291-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1401667/000143774922015291/pbyi20220616_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-22-015291

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer